The Discovery & Analytical Solutions segment empowers scientists with advanced instruments, reagents, informatics, and software to accelerate life science research. This segment provides detection and imaging technologies, along with contract research and laboratory services, enabling breakthroughs in understanding complex biological systems. Analytical technologies, solutions, and services are also offered to assess the health of air, water, and soil. Furthermore, the segment supports farmers and food producers with solutions for optimizing agricultural practices and ensuring food safety. Analytical instrumentation caters to diverse industrial markets, including chemical, semiconductor, energy, and petrochemical sectors, driving innovation and efficiency across various industries.

The Diagnostics segment focuses on the early detection of genetic disorders and infectious diseases, providing instruments, reagents, assay platforms, and software products. These tools are crucial for testing and screening genetic abnormalities, disorders, and diseases, including Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Serving pharmaceutical and biotechnology companies, laboratories, academic institutions, public health authorities, and healthcare organizations, this segment plays a vital role in improving patient outcomes through early and accurate diagnostics.

Revvity's Cancer Research Solutions segment is dedicated to fueling the future of cancer science through innovative research tools and technologies. This segment focuses on developing and providing solutions for cancer research and discovery, including the VivoJect™ Image-Guided Injection System. By combining its trusted cancer research portfolio with advanced technologies, Revvity aims to accelerate breakthroughs in cancer understanding, diagnosis, and treatment. The segment supports researchers in academia, pharmaceutical companies, and biotechnology firms, enabling them to explore new avenues in cancer biology and develop novel therapeutic strategies. Revvity's commitment to cancer research is evident through its participation in major conferences like AACR, where it showcases its latest advancements and collaborations.